IPAD-DB ID | S01249 |
Name | Heptyl caffeate |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 6 H 2 2 O 4 |
Molecular Weight | 278.34 g/mol |
IUPAC Name | heptyl(E)-3-(3, 4-dihydroxyphenyl)prop-2-enoate |
InChI | InChI=1S/C16H22O4/c1-2-3-4-5-6-11-20-16(19)10-8-13-7-9-14(17)15(18)12-13/h7-10, 12, 17-18H, 2-6, 11H2, 1H3/b10-8+ |
InChIKey | MVBSOBMQLAJJRB-CSKARUKUSA-N |
Canonical SMILES | CCCCCCCOC(=O)C=CC1=CC(=C(C=C1)O)O |
PubChem CID | 12034742 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 278.34 |
Hac(Computed by SwissADME) | 20 |
Volume(Computed by ADMETlab 2.0) | 298.714 |
Density(Computed by ADMETlab 2.0) | 0.931 |
nRing(Computed by ADMETlab 2.0) | 1 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 8 |
Flexibility(Computed by ADMETlab 2.0) | 1.125 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.654 |
LogD(Computed by ADMETlab 2.0) | 3.39 |
logP(Computed by ADMETlab 2.0) | 4.335 |
TPSA(Computed by SwissADME) | 66.76 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 9 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -4.34 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 1 |
Bioavailability Score(Computed by SwissADME) | 0.55 |